Workshop on Monoclonal Antibodies in Cancer

October 1, 2010
Hyatt Regency Washington on Capitol Hill
Washington, D.C.

  

The primary audience for the 2010 Workshop includes scientist and clinicians from regulatory agencies, industry, and academics who are interested in understanding more about monoclonal antibodies (mAbs). The Workshop will facilitate interactive discussion on mechanisms of action responsible for clinical efficacy of monoclonal antibodies, mechanisms of resistance to monoclonal antibodies and how to best utilize current knowledge to develop more effective antibody-based cancer treatments.

Program planning is currently underway for this exciting workshop.  Stay tuned for more information.

 

Organizers

Glenn Dranoff, MD
Dana-Farber Cancer Institute

Ira Mellman, PhD
Genentech, Inc.

George J. Weiner, MD
University of Iowa